AVD

Business Context and Reporting Period

Company: American Vanguard Corporation (AVD)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2006
Business Overview: The Company operates as a holding company with its primary business conducted through subsidiary AMVAC Chemical Corporation, a specialty chemical manufacturer for agricultural and commercial uses. The Company aggregates its business into one reportable segment. Key activities include the development, manufacturing, and marketing of insecticides, fungicides, herbicides, and soil fumigants.

Key Financial Metrics (Year Ended Dec 31, 2006)

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 2% to $193.8 million, driven by approximately $16 million in sales from recently acquired product lines (Permethrin and Terbufos). This growth was partially offset by lower sales of certain corn soil and cotton insecticides.
• Profitability Decline: Net income decreased 19% to $15.4 million. Gross profit declined $3.3 million due to competitive pricing pressures, increased manufacturing overhead, and product mix changes.
• Expense Fluctuations: Operating expenses remained relatively flat ($53.1 million vs. $53.4 million). Selling and G&A expenses decreased, while freight, delivery, and warehousing costs increased significantly ($4.2 million) due to carrier rate hikes and distribution network expansion.
• Debt Expansion: Long-term debt increased significantly to $93.8 million (from $34.4 million) to finance acquisitions and capital expenditures. The Company entered a new $165 million credit facility in December 2006.
• Cash Flow Shift: Operating cash flow turned negative ($29.8 million used) compared to positive cash flow in 2005. This was primarily due to a $45.6 million increase in working capital requirements, specifically higher accounts receivable and inventory levels.

Guidance, Outlook, Risks, and Unusual Items

Acquisitions and Outlook

The Company continues to pursue a strategy of acquiring mature product lines from larger competitors. In 2006, it acquired the Permethrin line from Syngenta and the Terbufos line from BASF. Management expects to finance long-term liquidity requirements through operations and cash equivalents but noted that significant future growth may require additional financing.

Risks and Contingencies

• DBCP Litigation: The Company faces significant, ongoing litigation regarding the pesticide DBCP.
  • Nicaragua: Approximately 83 suits filed under Public Law 364 involving ~3,500 plaintiffs. While only two have been served, precedent suggests potential multi-million dollar judgments. The Company contests jurisdiction.
  • Other Jurisdictions: Pending suits in Hawaii, Mississippi, Louisiana, and the Ivory Coast involving banana workers alleging sterility and other injuries. The Company states it is too early to assess the probability of an unfavorable outcome in many of these cases.
• Environmental: Ongoing investigation and potential remediation at the Commerce, California facility under the Expedited Remedial Action Program (ERAP). Costs are uncertain and may be material.
• Customer Concentration: Three customers accounted for 44% of total sales in 2006 (United Agri Products, Agriliance, and Helena Chemical Company).
• Regulatory: Products are subject to EPA registration and re-registration, which incurs significant operating expenses ($2.9 million in 2006).

Unusual Items

The Company adopted SFAS 123(R) in 2006, recognizing a pre-tax stock-based compensation expense of $0.98 million, which reduced net income. Additionally, a non-recurring income tax expense of $0.35 million increased the effective tax rate to 41.8%.

Investor Verification Checklist

• DBCP Litigation Exposure: Verify the current status of the Nicaragua Public Law 364 suits and the potential financial impact of the ~3,500 plaintiffs, given the Company's assertion that it is "too early" to assess outcomes.
• Working Capital Efficiency: Investigate the $45.6 million increase in working capital usage, specifically the $22.3 million inventory build-up, to determine if this represents strategic stockpiling or potential obsolescence risks.
• Debt Service Capacity: Assess the impact of the new $165 million credit facility and the resulting interest expense ($3.4 million in 2006) on future cash flows, especially given the negative operating cash flow in 2006.
• Customer Concentration: Monitor the stability of relationships with the top three customers who represent 44% of revenue.
• Environmental Remediation Costs: Track the progress of the Commerce, California facility investigation for potential future capital outlays.